Certara, Inc. (CERT) Reports Next Week: Wall Street Expects Earnings Growth

Core Viewpoint - The market anticipates Certara, Inc. (CERT) to report a year-over-year earnings increase driven by higher revenues when it releases its quarterly results for June 2025 [1] Earnings Expectations - Certara is expected to post quarterly earnings of $0.10 per share, reflecting a year-over-year increase of +42.9% [3] - Revenues are projected to reach $103.56 million, which is an 11% increase from the same quarter last year [3] Estimate Revisions - The consensus EPS estimate for Certara has remained unchanged over the last 30 days, indicating stability in analyst expectations [4] - The Most Accurate Estimate for Certara is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +2.44%, suggesting a bullish outlook from analysts [12] Earnings Surprise History - In the last reported quarter, Certara exceeded the expected earnings of $0.13 per share by delivering $0.14, resulting in a surprise of +7.69% [13] - Over the past four quarters, Certara has beaten consensus EPS estimates three times [14] Industry Context - Enanta Pharmaceuticals (ENTA), another player in the Zacks Medical - Biomedical and Genetics industry, is expected to report a loss of $1.25 per share for the same quarter, indicating a year-over-year decline of -16.8% [18] - Enanta's revenues are anticipated to be $15.1 million, down 16% from the previous year [19] - Despite a significant downward revision of 28.9% in the consensus EPS estimate for Enanta over the last 30 days, it currently has an Earnings ESP of +2.4% [19]